Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Pediatric Hematology and Oncology|October 30, 2009
Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failureTae Nemoto, Chihaya Imai, Utako Kaneko, et al.Cancer Research|November 8, 2013
T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killingKo Kudo, Chihaya Imai, Paolo Lorenzini, et al.Journal of Hematology & Oncology|March 18, 2016
Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemiaYozo Nakazawa, Kazuyuki Matsuda, Takashi Kurata, et al.Blood|July 10, 2014
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15Masaru Imamura, David Shook, Takahiro Kamiya, et al.Cancer Research|April 23, 2009
Expansion of highly cytotoxic human natural killer cells for cancer cell therapyHiroyuki Fujisaki, Harumi Kakuda, Noriko Shimasaki, et al.Biochemical and Biophysical Research Communications|November 27, 2025
Conditional deletion of glutaminase 1 in Tnfrsf11a-expressing cells reduces bone mass and induces postnatal growth retardation in miceShintaro Terashita, Yasuhito Yahara, Jun-Dal Kim, et al.Clinical & Translational Immunology|January 17, 2017
All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemiaTetsumi Yoshida, Keichiro Mihara, Yoshifumi Takei, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|August 6, 2013
Alveolar rhabdomyosarcoma after treatment of osteosarcomaYasushi Kasahara, Haruko Iwabuchi, Takayuki Takachi, et al.Journal of Pediatric Surgery|December 17, 2009
A 2-year-old boy with a stage III yolk sac tumor occurring in an intra-abdominal retained testisYutaka Hirayama, Masayuki Kubota, Masaru Imamura, et al.British Journal of Haematology|August 4, 2010
Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphomaKeichiro Mihara, Kazuyoshi Yanagihara, Misato Takigahira, et al.Pageof 8